首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Phototherapeutic keratectomy for bullous keratopathy.
【2h】

Phototherapeutic keratectomy for bullous keratopathy.

机译:光疗性角膜切除术用于大疱性角膜病变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIMS--This study was designed to investigate the therapeutic potential of excimer laser for recurrent painful erosions in patients not suited to treatment with penetrating keratoplasty. METHODS--Phototherapeutic keratectomy (PTK) with the excimer laser was performed prospectively on a series of 13 eyes of 12 patients with recurrent corneal erosions in connection with bullous keratopathy of varied aetiology. The main complaint of the patients before the treatment was frequent attacks of pain. The patients selected either refused corneal grafting or could not for a variety of reasons expect to profit visually from an operation. The treatment was performed with the MEL 60 Aesculap Meditec excimer laser using either a spot mode (five cases), a scanning mode (three cases), or a combination of both (five cases). RESULTS--All patients responded well to the treatment, and the pain subsided after a couple of weeks. In five cases (38.5%) a second treatment was necessary because of persistent pain, which was, however, much less than before the initial treatment. In four of these five patients small corneal bullae persisted. The visual performance of the seven patients with visual acuity better than 20/200 ameliorated in two cases and remained unchanged in four cases. One patient lost two Snellen lines after the laser treatment for terminal glaucoma. The mean follow up was 14.1 months (range 1-28 months). No complications were seen so far. CONCLUSION--It was concluded that PTK is a very promising and effective outpatient treatment for patients with bullous keratopathy. This therapeutic approach is not thought to have been described before.
机译:目的-这项研究旨在研究准分子激光对不适合穿透性角膜移植治疗的患者复发性疼痛糜烂的治疗潜力。方法-前瞻性对12例复发性角膜糜烂合并不同病因的大疱性角膜病变的患者的13眼进行了准分子激光光疗性角膜切除术(PTK)。治疗前患者的主要抱怨是疼痛的频繁发作。选择的患者要么拒绝角膜移植,要么由于各种原因而无法从手术中获得视觉收益。使用MEL 60 Aesculap Meditec准分子激光通过点模式(5种情况),扫描模式(3种情况)或两者结合(5种情况)进行治疗。结果-所有患者对治疗均反应良好,几周后疼痛减轻。在5例(38.5%)的病例中,由于持续性疼痛,因此需要第二次治疗,但是这比初始治疗之前要少得多。在这五名患者中的四名中,小角膜大疱持续存在。七名视敏度高于20/200的患者的视觉表现有2例得到改善,而4例则保持不变。一名患者接受激光治疗末期青光眼后丢失了两条Snellen线。平均随访14.1个月(1-28个月)。到目前为止,还没有发现并发症。结论-结论是PTK对大疱性角膜病变患者是一种非常有前途且有效的门诊治疗方法。认为以前没有描述过这种治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号